Antibiotics at the crossroads
Top Cited Papers
- 20 October 2004
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 431 (7011) , 899-902
- https://doi.org/10.1038/431899a
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Antibiotic Pipeline — Challenges, Costs, and ValuesNew England Journal of Medicine, 2004
- Surviving the Blockbuster SyndromeScience, 2004
- The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric OxideScience, 2003
- Why is big Pharma getting out of antibacterial drug discovery?Current Opinion in Microbiology, 2003
- Where will new antibiotics come from?Nature Reviews Microbiology, 2003
- Transcriptional Adaptation of Mycobacterium tuberculosis within MacrophagesThe Journal of Experimental Medicine, 2003
- Genetic strategies for antibacterial drug discoveryNature Reviews Genetics, 2003
- The future challenges facing the development of new antimicrobial drugsNature Reviews Drug Discovery, 2002
- Metabolic Enzymes of Mycobacteria Linked to Antioxidant Defense by a Thioredoxin-Like ProteinScience, 2002
- New Approaches to the Control of Infections Caused by Antibiotic-Resistant BacteriaJAMA, 1996